Assessing Neurocognition After Cerebrovascular Intervention
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Nov 13, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how carotid artery diseases, which can limit blood flow to the brain, affect thinking and memory skills, also known as neurocognitive function. The researchers want to see how changes in blood flow and certain blood markers relate to cognitive abilities before and after a treatment called carotid stenting, which helps improve blood flow. Participants will undergo several tests to assess their cognitive function and will have imaging and blood tests done at two points before the treatment and two points after.
To be eligible for this study, participants must be over 18 years old and have ultrasound evidence of significant narrowing in their carotid arteries—this means either having a 50% or greater blockage with symptoms or a 70% or greater blockage without symptoms. People who are unable to undergo an MRI, need emergency treatment, or cannot understand the study's risks and benefits will not be included. If you join the study, you can expect to complete some cognitive assessments and provide blood samples at different stages during the research process, helping to improve understanding of how carotid disease affects brain function.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients \>18 years of age
- • ultrasound evidence of carotid stenosis; in which the patient has either 50% or greater symptomatic carotid stenosis or 70% or greater asymptomatic carotid stenosis.
- Exclusion Criteria:
- • 1. patients \<18 years of age
- • 2. patients with without compatibility for MRI
- • 3. patients requiring carotid stenting for reasons not related to long-standing stenosis
- • 4. patients requiring emergency carotid stenting for acute symptoms such as crescendo transient ischemic attacks, intolerance of physiologic blood pressure.
- • 5. Patients that do not have appropriate capacity (i.e. understand the risks and benefits associated with this study) or are unable to consent for themselves will not be included in this study.
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Diego, California, United States
Patients applied
Trial Officials
Alexander A Khalessi, MD
Principal Investigator
UC San Diego
David R Santiago-Dieppa, MD
Study Director
UC San Diego
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials